Royal Bank Of Canada Infinity Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.14 - $0.24 $8 - $14	61 Added 6.79%	959 $0
Q1 2023 May 15, 2023	SELL	$0.16 - $0.74 $6 - $31	-43 Reduced 4.57%	898 $0
Q4 2022 Feb 14, 2023	BUY	$0.46 - $1.21 $16 - $43	36 Added 3.98%	941 $0
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $140 - $404	-238 Reduced 20.82%	905 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $2,075 - $5,082	-4,235 Reduced 78.75%	1,143 $0
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $12,160 - $34,334	-14,306 Reduced 72.68%	5,378 $6,000
Q4 2021 Feb 14, 2022	BUY	$1.86 - $3.36 $18,276 - $33,015	9,826 Added 99.68%	19,684 $45,000
Q3 2021 Nov 15, 2021	BUY	$1.52 - $3.82 $5,772 - $14,508	3,798 Added 62.67%	9,858 $34,000
Q2 2021 Aug 16, 2021	BUY	$2.66 - $3.47 $16,119 - $21,028	6,060 New	6,060 $18,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.